BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20691312)

  • 1. Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation.
    Maehama T; Okura H; Imai K; Yamada R; Obase K; Saito K; Hayashida A; Neishi Y; Kawamoto T; Yoshida K
    Am J Cardiol; 2010 Aug; 106(4):535-8. PubMed ID: 20691312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation.
    Khumri TM; Idupulapati M; Rader VJ; Nayyar S; Stoner CN; Main ML
    Am J Cardiol; 2007 Jun; 99(12):1733-6. PubMed ID: 17560884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Osborne JS; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):981-6. PubMed ID: 19659615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predicting embolic events in patients with nonvalvular atrial fibrillation: evaluation of the CHADS2 score in a Mediterranean population].
    Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Anguita M; López Granados A; Castillo JC; Arizón JM; Suárez de Lezo J
    Rev Esp Cardiol; 2008 Jan; 61(1):29-35. PubMed ID: 18221688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.
    Roldán V; Marín F; García-Herola A; Lip GY
    Thromb Res; 2005; 116(4):321-5. PubMed ID: 16038717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke prediction using mean platelet volume in patients with atrial fibrillation.
    Ha SI; Choi DH; Ki YJ; Yang JS; Park G; Chung JW; Koh YY; Chang KS; Hong SP
    Platelets; 2011; 22(6):408-14. PubMed ID: 21599611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.
    Poli D; Antonucci E; Marcucci R; Fatini C; Alterini B; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D
    Thromb Res; 2007; 121(3):347-52. PubMed ID: 17597186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
    Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
    G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation.
    Duygu H; Barisik V; Kurt H; Turk U; Ercan E; Kose S
    Europace; 2008 Feb; 10(2):210-4. PubMed ID: 18184662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.
    Conway DS; Buggins P; Hughes E; Lip GY
    Am Heart J; 2004 Sep; 148(3):462-6. PubMed ID: 15389233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation.
    Suzuki S; Sagara K; Otsuka T; Kano H; Matsuno S; Takai H; Uejima T; Oikawa Y; Koike A; Nagashima K; Kirigaya H; Yajima J; Tanabe H; Sawada H; Aizawa T; Yamashita T
    Am J Cardiol; 2013 Jun; 111(11):1602-7. PubMed ID: 23499279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation.
    Saeed M; Rahman A; Afzal A; Agoston I; Jammula P; Birnbaum Y; Ware DL; Uretsky BF; Schwarz ER; Rosanio S
    Int J Cardiol; 2006 Nov; 113(3):401-5. PubMed ID: 16822564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
    Nakagawa K; Hirai T; Takashima S; Fukuda N; Ohara K; Sasahara E; Taguchi Y; Dougu N; Nozawa T; Tanaka K; Inoue H
    Am J Cardiol; 2011 Mar; 107(6):912-6. PubMed ID: 21247518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of elevation of C-reactive protein in atrial fibrillation.
    Anderson JL; Allen Maycock CA; Lappé DL; Crandall BG; Horne BD; Bair TL; Morris SR; Li Q; Muhlestein JB;
    Am J Cardiol; 2004 Nov; 94(10):1255-9. PubMed ID: 15541240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A longitudinal study on left atrial thrombosis in patients with non-rheumatic atrial fibrillation treated with anticoagulants].
    Scardi S; Mazzone C; Pandullo C; Goldstein D; Perkan A
    G Ital Cardiol; 1997 Oct; 27(10):1036-43. PubMed ID: 9359051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of surgical ablation of atrial fibrillation in patients with rheumatic heart disease.
    Sternik L; Luria D; Glikson M; Malachy A; First M; Raanani E
    Ann Thorac Surg; 2010 May; 89(5):1437-42. PubMed ID: 20417758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors of left atrial thrombus and spontaneous echocardiographic contrast in patients with atrial fibrillation.
    Rader VJ; Khumri TM; Idupulapati M; Stoner CN; Magalski A; Main ML
    J Am Soc Echocardiogr; 2007 Oct; 20(10):1181-5. PubMed ID: 17566700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and atrial fibrillation: "evidence for the presence of inflammation in the perpetuation of the arrhythmia".
    Acevedo M; Corbalán R; Braun S; Pereira J; Navarrete C; Gonzalez I
    Int J Cardiol; 2006 Apr; 108(3):326-31. PubMed ID: 15985301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.